Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
How to taper off your GLP-1 If youre thinking about going off a GLP-1 medication, the latest research shows that its a good idea to do so slowly
Mid-dose program (144 mg total) With 144 mg across three months, the mid-dose program supports a higher weekly dose
Why It's Not GLP-1 (And Why That Matters) Drugs like semaglutide and tirzepatide work mostly by suppressing appetite
Retatrutide may be especially promising for: Patients who have struggled to lose weight despite GLP-1 therapy Individuals with obesity complicated by diabetes, fatty liver, or cardiovascular risk factors Patients seeking a more comprehensive metabolic reset rather than just weight reduction Safety & Current Status It's important to know: Retatrutide is not yet FDA-approved and is currently available only through clinical research and select specialty clinics
